The Use of Death Certificate Data to Characterize Mortality Associated With Respiratory Syncytial Virus, Unspecified Bronchiolitis, and Influenza in the United States, 1999-2018

J Infect Dis. 2022 Aug 15;226(Suppl 2):S255-S266. doi: 10.1093/infdis/jiac187.

Abstract

Background: Death certificate data can improve our understanding of the mortality burden associated with respiratory syncytial virus (RSV) and influenza.

Methods: We used International Classification of Diseases, Tenth Revision codes listed on death certificates to characterize deaths from 1999 to 2018 as RSV, influenza, and unspecified bronchiolitis. We described the distribution of each cause of death by age, sex, race/ethnicity, place of death, and contributing causes of death.

Results: Over the 20-year study period, RSV, bronchiolitis, and influenza were listed as the underlying causes of death on 932, 1046, and 52 293 death certificates, respectively. Children <1 year of age accounted for 39% of RSV and bronchiolitis deaths, while 72% of influenza deaths were in adults ≥65 years. Children <1 year were more likely to die outside of the hospital from RSV, bronchiolitis, or influenza compared to all causes (P < .01), and black infants had the highest mortality rate for all 3 causes. Most infants dying from RSV did not have a high-risk condition listed on the death certificate. Death certificates captured 20%-60% of estimated excess RSV-attributable mortality in infants and <1% in seniors.

Conclusions: Thorough reporting on death certificates is an important public health goal, especially as new therapeutics become available. Infants had higher odds of dying out of hospital from respiratory pathogens compared to other causes, and race/ethnicity alone did not explain this disparity.

Keywords: RSV; bronchiolitis; death certificates; excess mortality; infant mortality; influenza.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Aged
  • Bronchiolitis*
  • Child
  • Death Certificates
  • Humans
  • Infant
  • Influenza, Human*
  • Respiratory Syncytial Virus Infections*
  • Respiratory Syncytial Virus, Human*
  • United States / epidemiology